Quantum BioPharma’s hangover supplement accelerates alcohol metabolism in clinical research

Biotech specialist Quantum BioPharma has released findings from a clinical trial supporting the hangover-alleviating properties of its dietary supplement Unbuzzd. A double-blind, randomized, placebo-controlled crossover design study investigated its effects on alcohol intoxication and alcohol metabolism.

The research found that Unbuzzd “dramatically and rapidly” reduced blood alcohol concentration in study subjects while alleviating the symptoms of intoxication and hangover. This was observed at each subsequent measurement of blood alcohol concentration over a four-hour period.

The rate at which blood alcohol concentration was lowered was, on average for most participants, more than 40% faster within 30 minutes of consuming Unbuzzd compared to control subjects.

The company states that the quick reduction of blood alcohol after consuming Unbuzzd was “statistically significant” compared to placebo.

“This clinical trial shows that Unbuzzd is an important addition to the safe and responsible consumption of alcohol,” Zeeshan Saeed, CEO of Quantum BioPharma.

“Consumers now have the benefit of knowing that Unbuzzd can reduce alcohol intoxication, speed the reduction of blood alcohol concentration, restore mental alertness and well-being, and help them avoid the worst symptoms of a hangover.”

Cognitive boost

The male and female study participants were between the ages of 21 and 43 and weighed 119 to 232 pounds.

The positive effects of Unbuzzd occurred within 30 minutes after consumption of the dissolved powder. Unbuzzd was well tolerated and safe, with no reported product-related adverse effects.

The study participants reported statistically significant improvement in alertness within 30 minutes after consuming Unbuzzd. Participants felt made fewer cognitive errors, significantly outperforming placebo results.

Unbuzzd also lessened the elevation in heart rate and the drop in blood pressure that often accompanies alcohol intoxication, stabilizing both.

Additionally, it helped alleviate perceived impairment and mental fatigue caused by alcohol intoxication.

For hangover symptoms, participants in this study noted a statistically significant reduction in hangover symptoms. This included reduced cognitive and physical impairment and reduced headache compared to placebo results at both four hours (67% reduction in headache severity) and eight hours after consuming Unbuzzd.

“This study confirms the exceptional overall performance of Unbuzzd to help reduce the acute effects of alcohol intoxication,” says Dr. Andrzej Chruscinski, VP of Clinical and Scientific Affairs at Quantum Biopharma. “We are also pleased to see that there were no product-related side effects or safety concerns in this clinical study.”